Primary source: WEDI survey page, posted November 16, 2026. The page is a banner. The linked deck is the 18-page "WEDI 4th Survey Results" PDF, created the same day. Rule: CMS fact sheet, CMS-0057-F, January 17, 2024. Trade pickup: Healthcare Dive, Sara Heath, November 18, 2026.
WEDI posted its fourth interoperability and prior authorization survey on November 16, 2026. On the prior authorization API that CMS-0057-F requires by January 1, 2027, the October bar labels 10 percent of payer respondents at full completion. The number beside it is the one that changes the workqueue. Fifty-two percent said it is somewhat or very likely they will offer those APIs through an online portal. January 1 will not retire the portal.
Payer respondents at 100 percent completion on the prior authorization API, October 2026. The same bar labels 25 percent at about three-quarters, 37 percent at about halfway, 7 percent at about a quarter, and 20 percent at zero or unsure. The fourth survey drew 174 responses across payers, providers, clearinghouses, and vendors. The deck does not print a payer-only count.
This was the September and October 2026 round, after earlier rounds of 243, 173, and 83 responses. It is self-reported completion, not a CMS audit.
| Prior authorization API, payer respondents | February 2026 | October 2026 |
|---|---|---|
| 100 percent | 3 percent | 10 percent |
| About 75 percent | 10 percent | 25 percent |
| About 50 percent | 35 percent | 37 percent |
| About 25 percent | 39 percent | 7 percent |
| 0 percent or unsure | 13 percent | 20 percent |
The finished group grew, and so did the group at zero or unsure. The bucket is labeled "0%/Unsure." The deck does not split the two. Healthcare Dive reported that 17 percent have yet to start and that nearly two-thirds are at least halfway. The 10 percent matches the deck. The 17 percent does not. Use the deck's 20 percent.
October's top three payer challenges are delegated third parties connecting different systems, compliance timelines, and coordination with trading partners. Digitizing prior authorization policies and funding led earlier rounds. They are not this round's top three. The cost donut asks whether implementation cost more, less, or as expected, and it does not print the shares. Dive reported that 62 percent of payers said the project cost more than expected, and that no payer said less. The only 62 percent printed on the WEDI deck is a different question: all respondents who are moderately to very supportive of staggering CRD, DTR, and PAS. Do not move Dive's cost sentence onto that gauge.
Providers are not required to build the APIs. The October provider panel labels 7 percent at full completion and 21 percent at zero. Added to the middle labels, the printed figures come to 73 percent rather than 100, and the slide does not explain the gap. Separate gauges are cleaner: 50 percent say they are somewhat or very likely to meet the API provisions by January 1, 2027, and 71 percent say payer support for the API is very or extremely important.
The CMS fact sheet names Medicare Advantage organizations, Medicaid and CHIP fee-for-service and managed care, and QHP issuers on the federally facilitated exchanges. The APIs generally begin January 1, 2027. Drugs are excluded. A specific denial reason, public prior authorization metrics, and the 72-hour expedited and seven-calendar-day standard clocks began in 2026. The clocks do not apply to QHP issuers on the FFEs. The fact sheet does not print a dollar cost. Dive says CMS estimates $182 million in the first year and as much as $1.6 billion over a decade. That pair is Dive's account of CMS, not a line on the fact sheet.
This is RevCycleAI's read for the people still keying authorizations on January 2. A Medicare Advantage book can be in scope while a commercial book is not. The 52 percent figure means CRD, DTR, and PAS are expected inside a portal, not only as a transaction your EHR fires.
This survey is not the Humana path inside athenaOne, not Humana's December 1 Gold Card, and not the ONC and CMS testing sprint. Passing that test is not a compliance determination.
Ask each payer which of the four APIs is live on your contracts, and store the specific denial reason the 2026 rule already requires, including when it still arrives by portal or fax. Drugs are outside that requirement. In the October bars, 60 percent of clearinghouse respondents plan to run the exchanges for payer customers and 90 percent for provider customers. If the clearinghouse is your vendor, ask whether your auth status is in that feed.
Ten percent of payer respondents say the prior authorization API is finished. Twenty percent put it at zero or unsure. Fifty-two percent still point at a portal. Dive's 17 percent "not started" is Dive's. WEDI's label does not split zero from unsure. The decision clock and the specific denial reason are already 2026 rules. The seven-day clock does not cover QHP issuers on the federal exchange.
Build the workqueue for a mixed January, and log the denial reason whether or not an API sent it. The deck does not give a payer-only sample size, a named plan, or a printed share on the cost donut. Dive's 62 percent and its $182 million and $1.6 billion are Dive's. The WEDI 62 percent is support for staggering the three guides. Use the bar you can point at.
Prior authorization deadlines, with the survey bar left on the bar WEDI printed.
Sources: WEDI page, November 16, 2026 (opened; banner plus link). Deck: "WEDI 4th Survey Results," 18 pages, created November 16, 2026 (PDF opened). Response counts, the payer bars, the October challenge ranking, the 52 percent portal figure, the unlabeled cost donut, the 62 percent staggering gauge, the provider panel labels, the 50 percent and 71 percent provider gauges, and the clearinghouse 60 percent and 90 percent bars are the deck's. Provider labels as read sum to 73 percent; the deck does not explain that. CMS fact sheet, CMS-0057-F, January 17, 2024 (page opened). Impacted payers, API dates, the drug exclusion, the 72-hour and seven-day clocks excluding QHP issuers on the FFEs, the specific denial reason, and public metrics are the fact sheet's. The fact sheet does not print $182 million or $1.6 billion. Healthcare Dive, Sara Heath, November 18, 2026 (page opened). The 17 percent, the 62 percent cost sentence, and the CMS cost estimates are Dive's. Medicaid Monitor restates Dive and is not a separate count. Becker's returned HTTP 403 and is not used. The Humana, Gold Card, and ONC testing articles are different events. The analysis section is our read.